# Eton Pharmaceuticals, Inc. (ETON) stock price

URL: https://funkfolio.com/stock/ETON

> Eton Pharmaceuticals, Inc. (ETON) trades at $63.65, is worth $1.84B, is priced at 41.3× earnings and scores 51/100. Valuation, financials and signals.

---

## Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals, Inc. (ETON) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $63.65, down 0.36% on the day, which values the company at $1.84B. Price as of 17 Nov 2026, 21:35 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $63.65 −0.36% today
- **Market value:** $1.84B
- **P/E ratio:** 41.3× last 12 months
- **Forward P/E:** 19.3×
- **Funk Score:** 51/100
- **Against its own history:** Well above its usual price usual price $13.21
- **200-week average:** $15.19 319% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 21:35 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Eton Pharmaceuticals, Inc. in more detail

ETON trades at 41.3× its last twelve months' earnings, 19.3× next year's expected earnings, 13.0× sales. Measured against its own history, the price is 382% above what its usual multiples would imply ($13.21) — well above its usual price. It sits 319% above its 200-week average of $15.19.

Over the last five fiscal years Eton Pharmaceuticals, Inc. has compounded revenue 359.6% a year. Its Funk Score is 51 out of 100 (financial strength 7.5, profitability 3.1, growth 9.3, value 0.3, each out of 10).

In its favour: Altman Z in the safe zone. Worth checking: Share count keeps rising; Gross margin is shrinking.

1 of the superinvestors tracked here hold ETON, including Polen Capital team (0.1% of the portfolio).

### Superinvestors holding ETON

1 of the investors tracked here report a position in their latest 13F filing.

- [Polen Capital team Polen Capital Management](https://funkfolio.com/gurus/polen-capital) 0.06% of portfolio · $5.4M · added · Q3 2026

### Eton Pharmaceuticals, Inc. (ETON): questions and answers

**What is ETON's P/E ratio?**

Eton Pharmaceuticals, Inc. trades at 41.3× its last twelve months' earnings and 19.3× next year's expected earnings.

**What is Eton Pharmaceuticals, Inc.'s market cap?**

Eton Pharmaceuticals, Inc. is valued at $1.84B at a share price of $63.65.

**Is ETON overvalued or undervalued?**

Against its own history, ETON is well above its usual price: the price is 382% above the $13.21 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is ETON above its 200-week moving average?**

Yes. ETON is 319.1% above its 200-week average of $15.19. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Eton Pharmaceuticals, Inc. growing?**

Over the last five fiscal years Eton Pharmaceuticals, Inc.'s revenue grew 359.6% a year.

**Does ETON pay a dividend?**

Eton Pharmaceuticals, Inc. does not currently pay a regular dividend.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Eton Pharmaceuticals, Inc. (ETON) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ETON

Underlying data: Yahoo Finance; company filings with the SEC.
